ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Infectious Disease

Top Infectious Disease Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARIANA LOOR MD

Infectious Disease

22,273

$1.11M

1217
1000 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 47%

$50
Average prescription price

Avg: $351

PATRICIA LEON MD

Infectious Disease

17,814

$646K

352
321 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 47%

$36
Average prescription price

Avg: $351

USHA AGARWAL MD

Infectious Disease

15,757

$860K

781
582 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 47%

$55
Average prescription price

Avg: $351

VERONICA VERSARI M.D.

Infectious Disease

15,101

$502K

747
666 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 47%

$33
Average prescription price

Avg: $351

BRIAN ELLIOTT MD

Infectious Disease

14,209

$3.96M

570
353 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 47%

$279
Average prescription price

Avg: $351

JEFFREY LEVENSON M.D.

Infectious Disease

13,629

$2.81M

600
301 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 47%

$206
Average prescription price

Avg: $351

ROBERT CATALLA MD

Infectious Disease

11,843

$6.25M

283
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 47%

$528
Average prescription price

Avg: $351

MARK WHITESIDE M.D.

Infectious Disease

11,330

$2.06M

406
171 are 65+

19%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 47%

$182
Average prescription price

Avg: $351

SHARI KLINGER M.D.

Infectious Disease

11,034

$4.35M

144
20 are 65+

15%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 47%

$394
Average prescription price

Avg: $351

LESLIE DIAZ MD

Infectious Disease

9,316

$3.78M

487
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 47%

$406
Average prescription price

Avg: $351

MICHAEL DUNN M.D.

Infectious Disease

9,030

$3.68M

216
41 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 47%

$407
Average prescription price

Avg: $351

ANDREA BALCONIS MD

Infectious Disease

8,948

$3.52M

176
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 47%

$393
Average prescription price

Avg: $351

RONICA KLUGE MD

Infectious Disease

7,872

$821K

641
583 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 47%

$104
Average prescription price

Avg: $351

VANESSA SILEBI MD

Infectious Disease

7,606

$3.96M

149
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 47%

$520
Average prescription price

Avg: $351

NARESH MENEZES M.D.

Infectious Disease

6,492

$1.04M

555
398 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 47%

$161
Average prescription price

Avg: $351

EDWIN DEJESUS MD

Infectious Disease

6,485

$4.15M

344
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 47%

$640
Average prescription price

Avg: $351

MARGARET GORENSEK M.D.

Infectious Disease

5,752

$2.48M

249
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 47%

$432
Average prescription price

Avg: $351

MOTI RAMGOPAL MD

Infectious Disease

5,588

$2.92M

413
183 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 47%

$523
Average prescription price

Avg: $351

JENNIFER BUSH ARNP

Infectious Disease

5,381

$197K

435
317 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 47%

$37
Average prescription price

Avg: $351

FEDERICO HINESTROSA MD

Infectious Disease

4,957

$3.43M

257
37 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

72%
prescriptions for brand name drugs

Avg: 47%

$692
Average prescription price

Avg: $351

GEORGE CARDEN M.D.

Infectious Disease

4,781

$484K

254
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 47%

$101
Average prescription price

Avg: $351

STEPHEN SYMES MD

Infectious Disease

4,707

$1.71M

194
67 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 47%

$363
Average prescription price

Avg: $351

HERNAN CHANG M.D,

Infectious Disease

4,683

$346K

230
142 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 47%

$74
Average prescription price

Avg: $351

JAMES DWYER D.O.

Infectious Disease

4,572

$2.07M

265
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 47%

$453
Average prescription price

Avg: $351

BRENT LAARTZ MD

Infectious Disease

4,442

$1.81M

160
34 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 47%

$408
Average prescription price

Avg: $351

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank